Neutrophil subsets enhance the efficacy of host-directed therapy in pneumococcal pneumonia.

Autor: Matarazzo L; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 9017 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille, France., Costa C; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 9017 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille, France., Porte R; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 9017 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille, France., Saliou JM; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41 - UAR 2014 - PLBS - Plateformes Lilloises de Biologie & Santé, F-59000 Lille, France., Figeac M; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41 - UAR 2014 - PLBS - Plateformes Lilloises de Biologie & Santé, F-59000 Lille, France., Delahaye F; Univ. Lille, Inserm UMR1283, CNRS UMR8199, European Genomic Institute for Diabetes (EGID), Institut Pasteur de Lille, CHU de Lille, 1 place de Verdun, F-59000, Lille, France., Bonnefond A; Univ. Lille, Inserm UMR1283, CNRS UMR8199, European Genomic Institute for Diabetes (EGID), Institut Pasteur de Lille, CHU de Lille, 1 place de Verdun, F-59000, Lille, France., Kloeckner B; Gustave Roussy Cancer Campus, INSERM, Team Myeloid Cell Development, F-94800 Villejuif, France., Silvin A; Gustave Roussy Cancer Campus, INSERM, Team Myeloid Cell Development, F-94800 Villejuif, France., Ginhoux F; Gustave Roussy Cancer Campus, INSERM, Team Myeloid Cell Development, F-94800 Villejuif, France., Faveeuw C; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 9017 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille, France., Baldry M; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 9017 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille, France., Carnoy C; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 9017 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille, France. Electronic address: christophe.carnoy@univ-lille.fr., Sirard JC; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 9017 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille, France. Electronic address: jean-claude.sirard@inserm.fr.

Publikováno v: Mucosal immunology [Mucosal Immunol] 2024 Nov 24. Date of Electronic Publication: 2024 Nov 24.

Targeted delivery of flagellin by nebulization offers optimized respiratory immunity and defense against pneumococcal pneumonia.

Autor: Baldry M; Univ. Lille CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 9017 - CIIL - Center for Infection and Immunity of Lille, Lille, France., Costa C; Univ. Lille CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 9017 - CIIL - Center for Infection and Immunity of Lille, Lille, France., Zeroual Y; Univ. Lille CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 9017 - CIIL - Center for Infection and Immunity of Lille, Lille, France., Cayet D; Univ. Lille CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 9017 - CIIL - Center for Infection and Immunity of Lille, Lille, France., Pardessus J; INSERM, Respiratory Disease Research Centre, Tours, France.; University of Tours, Tours, France., Soulard D; Univ. Lille CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 9017 - CIIL - Center for Infection and Immunity of Lille, Lille, France., Wallet F; Univ. Lille CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 9017 - CIIL - Center for Infection and Immunity of Lille, Lille, France., Beury D; Univ. Lille CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41 - UAR 2014 - PLBS - Plateformes Lilloises de Biologie & Santé, Lille, France., Hot D; Univ. Lille CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41 - UAR 2014 - PLBS - Plateformes Lilloises de Biologie & Santé, Lille, France., MacLoughlin R; Aerogen IDA Business Park, Dangan, Galway, Ireland., Heuzé-Vourc'h N; INSERM, Respiratory Disease Research Centre, Tours, France.; University of Tours, Tours, France., Sirard J-C; Univ. Lille CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 9017 - CIIL - Center for Infection and Immunity of Lille, Lille, France., Carnoy C; Univ. Lille CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 9017 - CIIL - Center for Infection and Immunity of Lille, Lille, France.

Publikováno v: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2024 Oct 31, pp. e0086624. Date of Electronic Publication: 2024 Oct 31.

A cost-effective and enhanced mesenchymal stem cell expansion platform with internal plasma-activated biofunctional interfaces.

Autor: Zhang A; School of Biomedical Engineering, University of Sydney, NSW 2006, Australia.; School of Physics, University of Sydney, NSW 2006, Australia.; Sydney Nano Institute, University of Sydney, NSW 2006, Australia., Wong JKU; Charles Perkins Centre, University of Sydney, NSW 2006, Australia.; School of Life and Environmental Sciences, University of Sydney, NSW 2006, Australia.; Sydney Nano Institute, University of Sydney, NSW 2006, Australia., Redzikultsava K; School of Biomedical Engineering, University of Sydney, NSW 2006, Australia.; School of Physics, University of Sydney, NSW 2006, Australia., Baldry M; School of Biomedical Engineering, University of Sydney, NSW 2006, Australia.; School of Physics, University of Sydney, NSW 2006, Australia.; Sydney Nano Institute, University of Sydney, NSW 2006, Australia., Alavi SK; School of Biomedical Engineering, University of Sydney, NSW 2006, Australia.; School of Physics, University of Sydney, NSW 2006, Australia., Wang Z; Charles Perkins Centre, University of Sydney, NSW 2006, Australia.; School of Life and Environmental Sciences, University of Sydney, NSW 2006, Australia., van Koten E; School of Physics, University of Sydney, NSW 2006, Australia., Weiss A; Charles Perkins Centre, University of Sydney, NSW 2006, Australia.; School of Life and Environmental Sciences, University of Sydney, NSW 2006, Australia., Bilek M; School of Biomedical Engineering, University of Sydney, NSW 2006, Australia.; School of Physics, University of Sydney, NSW 2006, Australia.; Charles Perkins Centre, University of Sydney, NSW 2006, Australia.; Sydney Nano Institute, University of Sydney, NSW 2006, Australia., Yeo GC; Charles Perkins Centre, University of Sydney, NSW 2006, Australia.; School of Life and Environmental Sciences, University of Sydney, NSW 2006, Australia., Akhavan B; School of Biomedical Engineering, University of Sydney, NSW 2006, Australia.; School of Physics, University of Sydney, NSW 2006, Australia.; Sydney Nano Institute, University of Sydney, NSW 2006, Australia.; School of Engineering, University of Newcastle, Callaghan, NSW 2308, Australia.; Hunter Medical Research Institute (HMRI), Precision Medicine Program, New Lambton Heights, NSW, 2305, Australia.

Publikováno v: Materials today. Bio [Mater Today Bio] 2023 Jul 07; Vol. 22, pp. 100727. Date of Electronic Publication: 2023 Jul 07 (Print Publication: 2023).

Competence remodels the pneumococcal cell wall exposing key surface virulence factors that mediate increased host adherence.

Autor: Minhas V; Department of Fundamental Microbiology, Faculty of Biology and Medicine, University of Lausanne, Biophore Building, Lausanne, Switzerland., Domenech A; Department of Fundamental Microbiology, Faculty of Biology and Medicine, University of Lausanne, Biophore Building, Lausanne, Switzerland., Synefiaridou D; Department of Fundamental Microbiology, Faculty of Biology and Medicine, University of Lausanne, Biophore Building, Lausanne, Switzerland., Straume D; Department of Chemistry, Biotechnology and Food Science, Norwegian University of Life Sciences, Ås, Norway., Brendel M; Department of Molecular Genetics and Infection Biology, Interfaculty Institute for Genetics and Functional Genomics, Center for Functional Genomics of Microbes, Universität Greifswald, Greifswald, Germany., Cebrero G; Biozentrum, University of Basel, Basel, Switzerland., Liu X; Department of Fundamental Microbiology, Faculty of Biology and Medicine, University of Lausanne, Biophore Building, Lausanne, Switzerland.; Guangdong Key Laboratory for Genome Stability and Human Disease Prevention, Department of Pharmacology, International Cancer Center, Shenzhen University Health Science Center, Shenzhen, China., Costa C; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur Lille, U1019 - UMR 9017 - CIIL - Center for Infection and Immunity of Lille, Lille, France., Baldry M; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur Lille, U1019 - UMR 9017 - CIIL - Center for Infection and Immunity of Lille, Lille, France., Sirard JC; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur Lille, U1019 - UMR 9017 - CIIL - Center for Infection and Immunity of Lille, Lille, France., Perez C; Biozentrum, University of Basel, Basel, Switzerland., Gisch N; Division of Bioanalytical Chemistry, Priority Area Infections, Research Center Borstel, Leibniz Lung Center, Borstel, Germany., Hammerschmidt S; Department of Molecular Genetics and Infection Biology, Interfaculty Institute for Genetics and Functional Genomics, Center for Functional Genomics of Microbes, Universität Greifswald, Greifswald, Germany., Håvarstein LS; Department of Chemistry, Biotechnology and Food Science, Norwegian University of Life Sciences, Ås, Norway., Veening JW; Department of Fundamental Microbiology, Faculty of Biology and Medicine, University of Lausanne, Biophore Building, Lausanne, Switzerland.

Publikováno v: PLoS biology [PLoS Biol] 2023 Jan 30; Vol. 21 (1), pp. e3001990. Date of Electronic Publication: 2023 Jan 30 (Print Publication: 2023).

Soluble C-Type Lectin-Receptor Ligands Stimulate ROS Production in Dendritic Cells and Potentiate Killing of MRSA as Well as the MRSA Induced IL-12 Production.

Autor: Eld HMS; Department of Veterinary and Animal Sciences, University of Copenhagen, Frederiksberg, Denmark., Johnsen PR; Department of Veterinary and Animal Sciences, University of Copenhagen, Frederiksberg, Denmark., Nielsen EM; Department of Veterinary and Animal Sciences, University of Copenhagen, Frederiksberg, Denmark., Jørgensen FZ; Department of Veterinary and Animal Sciences, University of Copenhagen, Frederiksberg, Denmark., Lindstrøm-Svendsen M; Department of Veterinary and Animal Sciences, University of Copenhagen, Frederiksberg, Denmark., Baldry M; Department of Veterinary and Animal Sciences, University of Copenhagen, Frederiksberg, Denmark., Ingmer H; Department of Veterinary and Animal Sciences, University of Copenhagen, Frederiksberg, Denmark., Frøkiær H; Department of Veterinary and Animal Sciences, University of Copenhagen, Frederiksberg, Denmark.

Publikováno v: Frontiers in immunology [Front Immunol] 2022 Mar 21; Vol. 13, pp. 845881. Date of Electronic Publication: 2022 Mar 21 (Print Publication: 2022).